32
Nisin is a 34 amino acid antimicrobial peptide produced by strains of Lactococcus lactis subsp. lactis micelles, which then interact via hydrogen bonding to form secondary micelles (Kandrac et al., 2006; Partay et 48 al., 2007; Small, 1968) . The minimum bile salt concentration required for micelle formation is termed the 49 critical micelle concentration (CMC) . As the concentration of sodium ions affects the CMC, experiments with 50 bile salts are commonly performed in 0.15 moles/L Na + solutions to simulate physiological conditions 51 (Hofmann and Hagey, 2008) . In a 0.15 moles/L Na + solution, most bile salts have a CMC below 10 52 millimoles/L (Hofmann and Roda, 1984) ; 10 millimoles/L is also the bile salt concentration recommended for 53 simulating physiological conditions during in vitro digestion (Minekus et al., 2014) .
54
Previous digestion studies on nisin have focussed on pancreatic enzymes from the small intestine and 55 those that investigated the nisin fragments produced by digestion used enzymes individually and often used 56 digestions in excess of 20 h (Chan et al., 1996; Heinemann and Williams, 1966; Jarvis and Mahoney, 1969;  57 Slootweg et al., 2013) . In order to study how nisin is digested under more physiologically relevant conditions, the INFOGEST method, a recently developed standardized static method for the digestion of food (Minekus et al., 2014) was utilised. This method is the consensus of an international network of scientists and is based on M A N U S C R I P T 
A C C E P T E D ACCEPTED MANUSCRIPT

83
The initial nisin concentration was chosen so that the nisin concentration in the digestion product would be 84 sufficient for quantification by reversed phase -high performance liquid chromatography (RP-HPLC). The
85
digestion containing nisin and all digestion components was performed as follows: for the oral stage 5 mL of an 86 8.7 mg/mL nisin solution was combined with simulated salivary fluid (SSF) and salivary amylase (75 U/mL in 87 final oral solution) to a final total volume of 10 mL; this was incubated at 37 °C for 2 minutes. For the gastric 88 stage, the sample pH was adjusted to 3 using dilute HCl and combined with simulated gastric fluid (SGF) and pepsin (2,000 U/mL in final gastric solution) to a final total volume of 20 mL; this was incubated at 37 °C for 2 M A N U S C R I P T A C C E P T E D 
114
The molecular mass of the RP-HPLC peaks were determined using MALDI TOF MS using an Axima 115 TOF 2 mass spectrometer (Shimadzu Biotech, Kyoto, Japan) as previously described (Field et al., 2012) .
Biological activity was estimated by agar diffusion activity assays (Ryan et al., 1996) 
169
Performing the small intestinal stage of digestion with bile and/or pancreatin resulted in no intact nisin 170 being detectable by RP-HPLC (Table 1 ) and the products of digestions that included bile had greater
171
antibacterial activity than similar digestions without bile.
172
The highest antibacterial activity was in digestions without pancreatin; this correlates with previous
173
reports that pancreatin is primarily responsible for nisin digestion (Heinemann and Williams, 1966 
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Analyses of nisin fragments
181
As the products of digestions involving pancreatin demonstrated antibacterial activity that could not be 182 accounted for by the bile or digestive enzymes, the activity was likely due to fragments of nisin. To determine 183 which nisin fragments were produced and which of these were bioactive, the digestion products were separated 184 by RP-HPLC and the fractions collected (Fig. 1B) . The fractions were analysed using MALDI-TOF mass 185 spectrometry and by activity assay (Fig. 2) . Digestions with pancreatin produced peptides with molecular 186 masses corresponding to the theoretical and published molecular masses of nisin fragments 1-12, 1-20, 1-21, 1-187 29 and 1-32 and also a peptide with a molecular mass within two daltons of the theoretical mass of nisin 188 fragment 1-11 (Table 2) .
189
Major peaks on the RP-HPLC traces ( , 1996) . Nisin fragment 1-32 has been produced 212 by a 6 day acid treatment (Chan et al., 1989; Chan et al., 1996) . To the authors knowledge it has not been 213 previously demonstrated that these fragments can be produced under physiological conditions.
214
In Table 2 it is shown that the molecular masses observed in Fig. 2 As bile had been shown to increase nisin activity (Table 1) and alter its digestion (Table 2) 
233
All these surfactants were at a molar excess over the nisin component (100 µg/mL nisin ≈ 0.03 millimoles/L 234 nisin).
235
To investigate how surfactants affected the MIC of nisin when determined by activity assays; serial dilutions were performed in a MOPS/NaCl diluent on its own and with each of the surfactants, with a starting M A N U S C R I P T
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greater reduction was caused by Tween ® 80 and Triton™ X-100 and both of these reduced the MIC by the same 239 amount (Table 3) . This implies that nisin interacts differently with bile compared to the other surfactants.
binding to glass or polypropylene assay containers through competition with the peptides for binding sites on 242 the container or interacting with the binding sites on the peptides, primarily through hydrophobic interactions 243 (Duncan et al., 1995; Joosten and Nunez, 1995) . If nisin activity was increased by bile, through the formation of 244 a peptide-surfactant complex, there would also be an increase in the particle size of the bile salt micelle.
245
The effect of nisin-surfactant interaction on particle size was examined by AFM, turbidity and DLS.
246
AFM analysis of bile with and without nisin ( Fig. 3A and B) showed individual particles whose cross-sections 247 had z-heights ranging from 20 to 190 nm, which was similar to the z-average means obtained by DLS for bile
248
(100 nm ± 5) and bile with nisin (118 nm ± 9) ( Fig. 3D ) and similar to the published values for bile salt 
250
The turbidity of a system relates to both the size and density of particles that scatter light. In Fig. 3C ,
251
nisin was solubilised in a range of surfactants and turbidity increased with increasing nisin concentration, with 252 the greatest turbidity increases occurring in the presence of bile. DLS (Fig. 3D) found that the z-average 253 diameter of 10 millimoles/L bile salts with 100 µg/mL nisin was significantly larger than that without nisin (p = 254 0.0123, n = 4). There was no significant change in particle size when nisin was in solution with Triton™ X-100
255
or Tween ® 80 (data not shown). To produce results of suitable quality by DLS, the samples were filtered and 256 measured at 20 °C and pH 7 without a buffer.
257
The particle size analysis (Fig. 3) suggests that nisin formed a complex with bile and this was different
258
to its interaction with other surfactants. In the activity analysis ( 
264
With respect to the mechanism for bile-nisin interaction, both hydrophobic and ionic interactions are 265 possible. Bile salts are anionic with a negative charge on an amino acid that is attached to one end of the main 266 body of the bile salt via a short hydrocarbon chain (Fig. 4) (Hofmann and Hagey, 2008; Small, 1968) . Nisin has M A N U S C R I P T
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C-terminal domain (Fig. 4) and this is responsible for its initial interaction with its negatively charged targets 269 (Breukink et al., 1997) . The oppositely charged terminal regions of bile salts and nisin make ionic interactions 270 likely. Bile salts are planar amphipathic molecules and thus have a hydrophobic and a hydrophilic side (Fig. 4) ;
271
when forming a primary micelle they orientate their hydrophobic sides towards each other, giving the micelle a 272 hydrophobic core (Fig. 4) (Hofmann and Hagey, 2008) . Nisin is also amphipathic with the C-terminal being
273
hydrophilic while the N-terminal is hydrophobic (Fig. 4) 
281
Having shown that nisin formed a complex with bile salts, which altered its digestion products, it was 282 investigated how much this affected its antibacterial activity after digestion. The loss of nisin activity during 283 digestion is primarily due to pancreatic enzymes (Section 3.1). To look specifically at whether bile could
284
attenuate the loss of nisin activity due to pancreatin, a simplified digestion was performed with pancreatin in 285 buffer and bile added at the beginning or end of the digestion and the activity of the product determined by 286 activity assay. The final concentration of bile salts was 0.3 millimoles/L so that the antibacterial activity of bile 287 salts would not distort the results of the activity assay. The MOPS/NaCl buffer (pH 7) that was used as a diluent
288
for the activity assay contained 0.3 millimoles/L bile salts, so that the surfactant effect would be consistent at all 289 stages of the assay. The addition of bile before or after a 2 h digestion resulted in MICs of 11.8 µg/mL (± 0.3, n 290 = 3) and 12.7 µg/mL (± 0.2, n = 3) respectively. Although statistically significant (p = 0.01), the difference in 291 activity was slight.
292
Although the presences or absence of bile in a static in vitro digestion had a significant effect on the 293 nisin fragments produced, this in turn had a negligible effect on antibacterial activity. As nisin fragments 1-12, (1996) . Surface location and orientation of the lantibiotic nisin bound to membrane-mimicking micelles of M A N U S C R I P T Nisin solution All components 0% (± 0) 22 µg/mL (± 5) Nisin solution All components except bile 0% (± 0) 41 µg/mL (± 2) Nisin solution All components except pancreatin 0% (± 0) 0.9 µg/mL (± 0.2) Nisin solution All components except pepsin, bile and pancreatin 48% (± 2) 2.9 µg/mL (± 0.5) H2O (no nisin)
405
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All components n/a 82 µg/mL (± 21) Nisin solution Not digested 100% 1.8 µg/mL (± 0.1) The digestion products were analysed by RP-HPLC and agar diffusion activity assay. The amount of nisin detected by RP-HPLC is expressed as a % of the total initial nisin. Activity is expressed as minimum inhibitory concentration (MIC, µg/mL). An equivalent MIC is given for the products of digestions without nisin; SD in brackets, n ≥ 3. Chan et al. (1996) . b Slootweg et al. (2013) . Table 3 Effect of surfactants on the minimum inhibitory concentration (MIC, µg/mL) of nisin in agar diffusion activity assays (SD in brackets, n =3). Six nisin fragments produced, four of which are bioactive.
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Bile forms a complex with nisin.
Bile alters the relative amounts of the nisin fragments produced by digestion.
